Boehringer Ingelheim Licenses BioMax's BioRS Software | GenomeWeb
NEW YORK (GenomeWeb News) — Boehringer Ingelheim will use BioMax’s BioRS Integration and Retrieval system as a data-integration platform to access public and private pharmaceutical information, BioMax said yesterday.
 
BioRS is designed to search multiple databases through web interfaces.
 
Financial terms of the agreement were not released.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.